Using community health workers and mobile health to improve HIV treatment outcomes
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
This study is testing whether using community health workers and mobile health tools can help people with HIV in the Deep South stick to their treatment and improve their health outcomes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 420 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Columbia University Academic / other |
| Locations | 5 sites (Hobson City, Alabama and 4 other locations) |
| Trial ID | NCT06472206 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on addressing gaps in HIV testing, antiretroviral therapy adherence, and viral suppression among people with HIV in the Deep South of the United States. The CHAMPS+ intervention combines mobile health technology with community health workers to provide support and counseling aimed at improving ART adherence and preventing HIV transmission. The study will develop culturally relevant materials and retention strategies to engage participants effectively, while evaluating the clinical effectiveness and sustainability of the intervention across multiple HIV care settings.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who are living with HIV, have an HIV-1 RNA level greater than 200 copies/mL, and own a smartphone.
Not a fit: Patients residing in nursing homes, prisons, or receiving inpatient psychiatric care, as well as those with terminal illnesses or planning to move out of the area, may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve HIV treatment outcomes and reduce transmission rates among underserved populations.
How similar studies have performed: Other studies have shown promise in using community health workers and mobile health interventions to improve health outcomes in similar populations, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be able to speak, read, and write in English; * Be above 18 years of age; * Be willing to participate in any assigned arm of the intervention; * Have an HIV-1 RNA level \>200 copies/mL; * Own a smartphone; * Be able and willing to provide informed consent for study participation and consent for access to medical records. * Live, work and or receive care in AL, LA, or MS Exclusion Criteria: * Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment; * Terminal illness with life expectancy \<6 months; and * Planning to move out of the area in the next 12 months.
Where this trial is running
Hobson City, Alabama and 4 other locations
- Health Services Center, Inc. — Hobson City, Alabama, United States (Recruiting)
- Unity Wellness Center — Opelika, Alabama, United States (Recruiting)
- Louisiana State University Health Sciences Center in New Orleans — New Orleans, Louisiana, United States (Recruiting)
- Tulane University — New Orleans, Louisiana, United States (Recruiting)
- University of Mississippi Medical Center — Jackson, Mississippi, United States (Recruiting)
Study contacts
- Principal investigator: Rebecca Schnall, PhD, MPH — Columbia University
- Study coordinator: Rebecca Schnall, PhD, MPH
- Email: rb897@columbia.edu
- Phone: 212-342-6886
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.